Gene | Position | CytoBand | Mutation | Exon | A.A substitution | Protein region | SIFT Prediction | Primary VAF | Axillary lymph VAF | Metastasis 1 VAF | Metastasis 2 VAF | Patient |
---|---|---|---|---|---|---|---|---|---|---|---|---|
AKAP1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP2 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP3 | chr12:4725047 | 12p13.32 | G > A | 5/5 | Ser807Leu | NA | damaging | 2% | – | 13% | 41%, 22%a | pat 19 |
AKAP4 | chrX:49958130 | Xp11.22 | A > G | 5/6 | Phe412Leu | NA | damaging | 0% | 0% | 22%b | 26% | pat 8 |
AKAP5 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP6 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP7 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP8 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP9 | chr7:91630327 | 7q21.2 | A > G | 8/50 | Ile366Val | close to bindning domain | tolerated | 4% | – | 24%, 36%a |  | pat 7 |
AKAP10 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP11 | chr13:42875448 | 13q14.11 | G > A | 8/13 | Asp856Asn | NA | tolerated | 0% | – | 8% |  | pat 12 |
AKAP12 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP13 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
AKAP14 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |